ReNeuron Shares Rise On Positive Data From Blindness Treatment Trial
LONDON (Alliance News) - Shares rose in ReNeuron Group PLC on Thursday after it reported positive efficacy in a phase one/two clinical trial of its hRPC cell therapy candidate for treating in the
Read more